Vaccination for Leukemia
Open Access
- 31 January 2006
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (1) , 13-18
- https://doi.org/10.1016/j.bbmt.2005.10.014
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trialThe Lancet, 2005
- CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemiaBlood, 2002
- Analysis of the Modulation of Transcriptional Activity in Myelopoiesis and LeukemogenesisMethods, 1999
- Adoptive immunotherapy with donor lymphocyte transfusionsCurrent Opinion in Oncology, 1997
- Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.Journal of Clinical Investigation, 1995
- Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility AntigenScience, 1995
- Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)Clinical and Experimental Immunology, 1995
- T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)Clinical and Experimental Immunology, 1994
- Myeloblastin/Proteinase 3 Belongs to the Set of Negatively Regulated Primary Response Genes Expressed During in Vitro Myeloid DifferentiationBiochemical and Biophysical Research Communications, 1994
- The Phylogeny of Proteinase 3/Myeloblastin, the Autoantigen in Wegener's Granulomatosis, and Myeloperoxidase as Shown by Immunohistochemical Studies on Human Leukemic Cell LinesClinical Immunology and Immunopathology, 1994